- 2019-07-25 09:03A Review of MS drugs in China
- 2019-07-25 09:03A Blockbuster to Arrive in the Multiple Sclerosis Area of China!
- 2019-07-24 08:50Market shares of overseas pharma enterprises approach 70% in China’s coagulation factor Ⅷ market
- 2019-07-24 08:50Novo Nordisk’s Recombinant Coagulation Factor Ⅷ Applied for Marketing Ahead of Chiatai Tianqing!
- 2019-07-24 08:50Biohaven’s Nurtec fails to obtain FDA approval for ALS
-
- 2019-07-22 08:33Development Status of Pilose Antler, a Traditional Chinese Medicinal Material
- 2019-07-22 08:33How was the Small Molecule Apixaban with Annual Sales of Nearly USD10 Billion “Tempered”?
- 2019-07-22 08:33Merck’s Recarbrio gets FDA approval for treatment of infections
- 2019-07-22 08:33FDA Approves Treatment for Complicated Urinary Tract, Complicated Intra-Abdominal Infections
- 2019-07-22 08:33Pear Therapeutics Announces FDA Submission for Somryst
-
- 2019-07-19 08:48Government takes measures to curtail mis-information via non-AYUSH researchers
- 2019-07-18 08:52USPTO Issues Patent for COM701, Anti-PD-1 Antibody Use
- 2019-07-18 08:52FDA Accepts BLA, Grants Priority Review for Crizanlizumab
- 2019-07-17 08:56Suspected counterfeit vaccines seized in Hong Kong
- 2019-07-17 08:56A Review of U.S. ANDA Approvals Received by Chinese Pharmaceutical Enterprises in the First Half of
-
- 2019-07-12 08:44Overview of the Approval Trends of Pharmaceutical Products in the First Half of 2019
- 2019-07-11 08:56Merck and Skyhawk Therapeutics sign collaboration agreement
- 2019-07-11 08:56Mainstream psoriasis drugs marketed in the world
- 2019-07-11 08:56Trovagene Initiates Enrollment for KRAS-Mutated Colorectal Cancer Trial
- 2019-07-11 08:56Competition in the RMB3 Billion Psoriasis Drug Market Turning White-hot!
-
- 2019-07-05 08:56CPhI.CN is recruiting pharmaceutical freelance writers!
- 2019-07-05 08:56Different Clinical Layouts of Chinese-produced Products for Marching into the Anti-PD-1 Monoclonal A
- 2019-07-04 08:58Hengrui’s Anti-PD-1 Monoclonal Antibody Formally Approved; A Review of Progress of Immunotherapy Dru
- 2019-07-03 08:32Multiple First Generics of the Hard-to-Imitate Budesonide, Salmeterol, and Coagulation Factor VIII,
- 2019-07-03 08:32Sino Biopharmaceutical’s R&D Investment Growing by 31% to Rank Fourth!
-
- 2019-07-02 08:50Global Patients Whining about the Production Suspension of the Cytarabine Manufacturer
- 2019-06-28 08:45AbbVie looks beyond Humira with $63 billion deal for Botox-maker Allergan
- 2019-06-26 08:39Greater Long-Term Decline in Stroke Seen Among Older Adults
- 2019-06-26 08:39FDA Expands Cystic Fibrosis Treatment Approval for Symdeko (Tezacaftor/ivacaftor) to Children Ages 6
- 2019-06-26 08:39FDA joins blockchain system for drug safety
-
- 2019-06-17 09:01Cordyceps Militaris and Cordycepin Extract: Real or Fake?
- 2019-06-13 09:23Death risk from sepsis lasts up to five years
- 2019-06-13 09:23FDA Approves Roche’s Venclexta for CLL
- 2019-06-13 09:23FDA OKs new administration options for GSK’s Nucala
- 2019-06-13 09:23Just 44% of UK health sector would trust humans over AI
-
- 2019-06-12 08:49Three more US states announce lawsuits against Purdue
- 2019-06-12 08:492003 to 2014 Saw Incidence of Herpes Zoster Drop in Children
- 2019-06-12 08:49CStone and Bayer to evaluate PD-L1 monoclonal antibody CS1001 in combination with regorafenib
- 2019-06-12 08:49Labcorp, QIAGEN announce companion diagnostic for metastatic breast cancer
- 2019-06-12 08:49Celgene Corporation and Acceleron Pharma Announce U.S. FDA Accepts Luspatercept Biologics License Ap
-
- 2019-06-12 08:49US FDA and EMA Accept Applications for Ozanimod for the Treatment of Relapsing Forms of Multiple Scl
- 2019-06-12 08:49Exeltis USA, Inc. Announces the Approval of Slynd (drospirenone), the First and Only Progestin-Only
- 2019-06-12 08:49PTC Therapeutics Receives FDA Approval for the Expansion of the Emflaza (deflazacort) Labeling to In
- 2019-06-11 08:51Naloxone Available in One in Three Philadelphia Pharmacies
- 2019-06-11 08:51Pharmaceutical intermediates market to see growth
-
- 2019-06-11 08:51Influenza A vaccine enters Phase IIb trial
- 2019-06-11 08:51Global contraceptive pill market to grow 6.6 percent
- 2019-06-11 08:51Nucala (mepolizumab) gains FDA approval for two new self-administration options
- 2019-06-11 08:50First treatment for cluster headaches approved in US
- 2019-06-10 08:58Prescription drug costs steadily soar, yet price transparency is lacking
-
- SunSirs: On February 19th, the Price of Imported Potassium Chloride Fell by 1.80%
- SunSirs: Costs Rose and Supply Increased, DOTP Prices Were Weak Consolidated after the Holiday
- SunSirs: After the Holiday, Plasticizer Manufacturers Resumed Production and DOP Supply Increased
- SunSirs: Costs Rose, Supply Increased, and DBP Prices Weakly Consolidated
- SunSirs: Poor Replenishment, the Price of Aluminum Fluoride Was Temporarily Stable after the Holiday
- SunSirs: On February 18th, the Domestic DBP Market Was Temporarily Stable
- SunSirs: The Price of Tetrachloroethylene Has Fallen Narrowly after the Hholiday, and Expectations A
- SunSirs: Demand Was Weak, Production Was Resumed, and Acetic Anhydride Prices Dropped after the Holi
- SunSirs: Demand Was Weak, Production Was Resumed, and Acetic Anhydride Prices Dropped after the Holi
- SunSirs: China Fuel Oil 180CST Market in 2024 may Maintain a Volatile Trend
- SunSirs: The Demand Varies, China Gasoline has Higher Resistance to Drop Compared to Diesel
- SunSirs: Just Entering February, the Dimethyl Carbonate Market Was Operating Steadily and Weakly
- SunSirs: The Market Price of Lithium Hydroxide Was Mainly Stable (January 29-February 5)
- SunSirs: The Price of Nitric Acid Had Dropped This Week (January 29-February 2)
- SunSirs : The Cement Market Prices in Hunan have been Declining fo rFour Consecutive Weeks
- SunSirs: As the New Year Approaching, the Trend of the Market for Isooctyl Acrylate
- SunSirs: The Domestic First-class Titanium Sponge Market Was Mainly Operating Weakly and Steadily (J
- SunSirs: The Market Price of Ferrous Lithium Phosphate Fell in January
- SunSirs: The Price of Sodium Metabisulfite Was Weaker in January
- SunSirs: China Domestic Ship Fuel Market Fluctuated and Rose in January, 2024
- SunSirs: The Lithium Hydroxide Market in January First Fell and Then Stabilized
- SunSirs: The NMP Market Weakly Declined in January
- SunSirs: Summary of Domestic Cobalt Market Trends on January 18th
- SunSirs: On January 18th, Prices of Some Domestic Dysprosium Terbium Series Products Increased
- SunSirs: The Potassium Carbonate Market Has Declined This Week (January 15-19)
- SunSirs: The Release of Demand Side Was Slow, and the Market for Isooctyl Acrylate Was Stable
- SunSirs: The Seamless Tube Market Had Been Operating Weakly and Steadily This Week (January 8-12)
- SunSirs: Sales Were Sluggish, Propane Continued to Decline
- SunSirs: Production and Sales are Weak, China DME Market is temporarily Stable
- SunSirs: Weak consolidation of China MTBE market